Earth Science Tech Inc. (ETST) Presents Fiscal Year-End Financial Results for March 31, 2026, Operating a Diversified Holding Company Model

• Earth Science Tech Inc. (OTC: ETST) recently reported year-end financial results for the fiscal year ending March 31, 2026
• Earth Science Tech acquires, manages, and operates companies in pharmaceuticals, real estate, telemedicine, healthcare services, and other industries.
• Results include increases in revenue, gross profit, net income, and total assets.

Earth Science Tech (OTC: ETST), a strategic holding company that acquires and manages a diverse portfolio of businesses, recently announced the financial results for the full fiscal year that ended on March 31, 2026 (https://ibn.fm/xRoIz).

The reported results include:

• An 8% revenue increase compared to the year ended March 31, 2025, with revenue rising to $35.7 million from $33.1 million.
• A 5% rise in gross profit, as it climbed to $25.5 million from $24.3 million.
• An 11% increase in net income, as it rose to $3.6 million from $3.3 million.
• Total assets that rose by 27%, going to $9 million from $7.1 million.

Earth Science Tech CEO, Giorgio R. Saumat, said that “Our fiscal 2026 results reflect the meaningful progress we have made over the last several years to build a business that is durable, self-sustaining and positioned for long-term growth.” He added that “These results are driven by the work we have done to better integrate the patient experience across our platform, from telemedicine to pharmacy to fulfillment. By owning more of that process, we serve patients effectively while building a stronger and more profitable business.”

Earth Science Tech builds value by acquiring and managing companies and operates a diverse portfolio of revenue-generating businesses. The company’s core exposure is in acquiring and scaling cash-flowing assets across healthcare, pharmaceutical compounding, and telemedicine. The goal is controlling interests in subsidiaries where operational oversight, regulatory compliance, and disciplined scaling, can drive durable growth, with an emphasis on capital discipline, execution, and long-term value creation.

Earth Science Tech currently has a large portfolio which includes compound pharmacies RxCompoundStore and Mister Meds, telehealth companies MyOnlineConsultation and DOConsultations, as well as Las Villas Health Care, which is both an online telehealth platform and brick-and-mortar clinic. It also operates real estate development firm Avenvi, plus Magnechef, a direct-to-consumer retail brand.

The team at Earth Science Tech is led by CEO and Chairman of the Board, Giorgio R. Saumat. Saumat is an investor and entrepreneur with more than 20 years of experience in investing, operating, and consulting for private businesses and investors. It also features a number of other seasoned professionals with a wealth of experience in areas like finance, technology, business development, and strategic development.

For more information, visit the Earth Science Tech website at www.EarthScienceTech.com.

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN